/A

Phase 1

• Conditions: MedDRA version: 19.0Level: LLTClassification code 10042080Term: Stomach cancerSystem Organ Class: 100000004864; MedDRA version: 19.0Level: LLTClassification code 10042089Term: Stomach cancer stage IV without metastasesSystem Organ Class: 100000004864; MedDRA version: 19.0Level: LLTClassification code 10042088Term: Stomach cancer stage IV with metastasesSystem Organ Class: 100000004864; Therapeutic area: Diseases [C] - Cancer [C04]

• Registration Number: EUCTR2016-002331-16-FR
• Lead Sponsor: Fédération Francophone de Cancérologie Digestive

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2016-10-19
• Last Update Posted: 8 July 2024

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: 506

Inclusion Criteria

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 206
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 300

Exclusion Criteria

Not provided

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Main Objective: ;Secondary Objective: ;Primary end point(s):